Press Room

25th Anniversary IOVS Special Issue on optical coherence tomography released - 7/14/2016

The journal Investigative Ophthalmology& Visual Science (IOVS) is commemorating the 25th anniversary of the development of optical coherence tomography (OCT) with the release of a special issue of more than 70 papers from authors on five continents.



Alzheimer’s detected before symptoms via new eye technology - 7/8/2016
Scientists may have overcome a major roadblock in the development of Alzheimer’s therapies by creating a new technology to observe ― in the back of the eye ― progression of the disease before the onset of symptoms

Infant visual reflex and accuracy may improve with age - 5/31/2016
A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements. The paper, “Development and learning of saccadic eye movements in 7-42 month-old children” was published in the Journal of Vision.

Supplement mimics neuroprotective effects of low-calorie diet - 5/16/2016
According to new research, injection of 3-hydroxybutyrate (3HB) offers similar protection as a low calorie diet against nerve degeneration in rats with glaucoma. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.

Pre-symptom Alzheimer’s disease detected with new eye scan - 5/5/2016
Early structural changes in the back of the eye — now visible with a newly developed eye scan — may indicate the onset of Alzheimer’s disease. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.

Blocking blue light improves sleep according to study - 5/4/2016
Building on existing evidence, vision researchers have found that limiting exposure to blue light after sunset increases the quality and length of sleep. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.

First ever combination of robotic and biological vision in humans - 5/4/2016
Scientistshave successfully implanted a prosthesis that restores some central vision inpatients with only limited peripheral vision remaining to them – the first timeartificial and natural vision has ever been integrated in humans. The researchis being presented at the 2016 Annual Meeting of the Association for Researchin Vision and Ophthalmology (ARVO) this week in Seattle, Wash.

Ebola may lead to blindness in survivors according to new findings - 5/4/2016
A new study has shown that Ebola survivors may be at risk of severe vision loss or blindness weeks after being declared virus-free. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.

Study finds blueberries may protect against dry eye disease - 5/4/2016
Pterostilbene(PS), a component of blueberries, have been found to protect against dry eyedisease according to a new study. The research is being presented at the 2016Annual Meeting of the Association for Research in Vision and Ophthalmology(ARVO) this week in Seattle, Wash.

Emerging trends and hot topics: Presented Wednesday, May 4 at the ARVO Annual Meeting - 5/4/2016
In their own words, First Authors at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology explain their findings.Their abstracts were designated as some of the newest and most innovative research presented on Wednesday, May 4.


First skin-to-eye stem cell transplant in humans successful - 5/3/2016
Researchers have safely transplanted stem cells derived from a patient’s skin to the back of the eye in an effort to restore vision. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.

Emerging trends and hot topics: Presented Tuesday, May 3 at the ARVO Annual Meeting - 5/3/2016

In their own words, First Authors at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology explain their findings.Their abstracts were designated as some of the newest and most innovative research presented on Tuesday, May 3.



Emerging trends and hot topics: Presented Monday, May 2 at the ARVO Annual Meeting - 5/2/2016
In their own words, First Authors at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology explain their findings.Their abstracts were designated as some of the newest and most innovative research presented on Monday, May 2.

Media Invitation: Press Conference at ARVO 2016 by Webcast - 5/1/2016
Press conference by webcast whole eye transplant and other eye research advances from the ARVO 2016 Annual Meeting

Emerging trends and hot topics: Presented Sunday, May 1 at the ARVO Annual Meeting - 5/1/2016

In their own words, First Authors at the 2016 Annual Meeting of theAssociation for Research in Vision and Ophthalmology explain their findings.Their abstracts were designated as some of the newest and most innovative research presented on Sunday, May 1.



Former Seahawks quarterback Jim Zorn and Congressman James McDermott, MD (WA 7) - 4/21/2016
More than 75% of all TBI patients experience visual disorders, including double vision, light sensitivity, difficulty reading print and even vision loss.

Can you trust your gut on a crowd’s mood? - 1/13/2016
There is good news for frequent public speakers. New research shows that individuals have the ability to quickly and accurately identify a crowd’s general emotion as focused or distracted, suggesting that we can trust our first impression of a crowd’s mood. 

Scientists find potential target for dry AMD - 11/2/2015

Scientists have good news for patients who suffer from currently untreatable dry age-related macular degeneration (dry AMD). In a new study, researchers identified a potential target for future therapies to slow the progression of the blinding condition. Published in Investigative Ophthalmology & Visual Science (IOVS), the findings indicate that treatments currently used for other conditions could also work for dry AMD.



Can your brain control how it loses control? - 8/13/2015
A new study may have unlocked understanding of a mysterious part of the brain — with implications for neurodegenerative conditions such as Alzheimer’s. The results, published in Translational Vision Science & Technology (TVST), open up new areas of research in the pursuit of neuroprotective therapies.

ARVO Foundation announces new David L. Epstein Award for glaucoma research - 8/2/2015
To honor the memory of a longtime leader in glaucoma treatment and research, the ARVO Foundation for Eye Research will present the Dr. David L. Epstein Award. The new award — a $100,000 prize — was established by the late Dr. Epstein's family and will be presented annually to a senior-level glaucoma researcher at the ARVO Annual Meeting.

12Next
Advertisement
Ozurdex through sept 1